- Associated Press - Monday, March 12, 2012

In a story Feb. 24 about weight loss drugs and a story March 8 about Orexigen Therapeutics Inc.’s quarterly earnings, The Associated Press inaccurately described the ingredients in Orexigen’s drug Contrave. The pill combines bupropion, the active ingredient in the antidepressant Wellbutrin, with the anti-addiction drug naltrexone. Naltrexone is not the active ingredient in Wellbutrin.

Sign up for Daily Newsletters

Manage Newsletters

Copyright © 2021 The Washington Times, LLC.

Please read our comment policy before commenting.


Click to Read More and View Comments

Click to Hide